System and method of modeling erythropoiesis and its management
First Claim
1. A method of adjusting a patient'"'"'s undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen comprising:
- a) obtaining patient parameters required for input into a model for predicting the patient'"'"'s hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen;
b) employing the patient parameters and an initially selected ESA administration regimen in the model to predict the patient'"'"'s hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen, wherein the model comprises the functions;
2 Assignments
0 Petitions
Accused Products
Abstract
A method of adjusting a patient'"'"'s undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen includes obtaining patient parameters required for input into a model for predicting the patient'"'"'s hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen, and employing the patient parameters and an initially selected EPO administration regimen in the model to predict the patient'"'"'s hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen. Optionally, if the patient'"'"'s hematocrit and/or hemoglobin concentration is not predicted by the model to be in the desired range at the predetermined time, the method includes employing the model with one or more different ESA administration regimens until the model predicts that the patient'"'"'s hematocrit and/or hemoglobin concentration will be in the desired range at the predetermined time. The method then includes administering ESA to the patient with an ESA administration regimen predicted to adjust the patient'"'"'s hematocrit and/or hemoglobin concentration to the desired range at the predetermined time. The method can be implemented in a computer system for adjusting a patient'"'"'s undesired hematocrit and/or hemoglobin concentration to a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen.
-
Citations
10 Claims
-
1. A method of adjusting a patient'"'"'s undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen comprising:
-
a) obtaining patient parameters required for input into a model for predicting the patient'"'"'s hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen; b) employing the patient parameters and an initially selected ESA administration regimen in the model to predict the patient'"'"'s hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen, wherein the model comprises the functions; - View Dependent Claims (2, 3, 4, 10)
-
-
5. A system for adjusting a patient'"'"'s undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen the system comprising:
-
a) an input means for determining patient parameters of the patient; b) a digital processor coupled to receive determined patient data from the input means, wherein the digital processor executes a modeling system in working memory, wherein the modeling system is configured to; i) employ the patient parameters and an initially selected ESA administration regimen in the model to predict the patient'"'"'s hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen, wherein the model comprises the functions; - View Dependent Claims (6, 7, 8)
-
-
9. A method of determining an erythropoiesis stimulating agent (ESA) administration regimen to bring a patient'"'"'s hematocrit and/or hemoglobin concentration into a desired range at a predetermined time comprising:
-
a) obtaining patient parameters required for input into a model for predicting the patient'"'"'s hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen; b) employing the patient parameters and an initially selected ESA administration regimen in the model to predict the patient'"'"'s hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen, wherein the model comprises the functions;
-
Specification